PATENT CLAIM ANALYSIS

Application Number: 15775312
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "234500"]

Abstract:
The present invention relates to a 7-azaindolin-2-one derivative or a pharmaceutically acceptable salt thereof, and the 7-azaindolin-2-one derivative or the pharmaceutically acceptable salt thereof can be favorably used as a medicinal material for inhibiting cancer growth and cancer metastasis.

Claim (Index 12):
A method for prevention or treatment of cancer disease, comprising administering to a subject in need thereof a therapeutically effective amount of the compound or the pharmaceutically acceptable salt thereof according to  claim 1  as an active ingredient.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.41379
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13196391', '12451466', '12223180', '13945924', '13106076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7507352303738949
- 35 USC 102 Novelty (BERT): 0.5236338892667417
- Combined Prediction Score: 0.7280250962631796
- Mean Citation Score: 311.092622
- Max Citation Score: 313.8167
- Similarity Product: 230.0615095983148

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test